{"log_id": 1306800531075147545, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0, "average": 0.903178, "min": 0.903178}, "location": {"width": 45, "top": 209, "height": 23, "left": 194}, "words": ")"}, {"probability": {"variance": 0.010971, "average": 0.916703, "min": 0.704932}, "location": {"width": 115, "top": 244, "height": 22, "left": 384}, "words": "给药推迟一周"}, {"probability": {"variance": 0.008747, "average": 0.95682, "min": 0.747712}, "location": {"width": 109, "top": 247, "height": 22, "left": 601}, "words": "给药推迟一周"}, {"probability": {"variance": 0.026552, "average": 0.868396, "min": 0.594275}, "location": {"width": 69, "top": 249, "height": 22, "left": 806}, "words": "停止治疗"}, {"probability": {"variance": 0.047452, "average": 0.745818, "min": 0.425592}, "location": {"width": 161, "top": 277, "height": 22, "left": 203}, "words": "变肉肠道"}, {"probability": {"variance": 0, "average": 0.993069, "min": 0.993069}, "location": {"width": 27, "top": 268, "height": 26, "left": 1102}, "words": "局"}, {"probability": {"variance": 1e-06, "average": 0.998964, "min": 0.996196}, "location": {"width": 238, "top": 398, "height": 29, "left": 194}, "words": "出现血液毒性的剂量调整"}, {"probability": {"variance": 0.000633, "average": 0.992564, "min": 0.872286}, "location": {"width": 510, "top": 400, "height": 32, "left": 473}, "words": "白细胞减少症是这一人群出现最多的不良反应,嗜中性粒"}, {"probability": {"variance": 0.018747, "average": 0.937148, "min": 0.500401}, "location": {"width": 408, "top": 447, "height": 30, "left": 150}, "words": "维胞减少症、贫血和血小板减少症也有出现"}, {"probability": {"variance": 0.007584, "average": 0.948501, "min": 0.716411}, "location": {"width": 220, "top": 497, "height": 28, "left": 195}, "words": "当病人ANC计数<1,000"}, {"probability": {"variance": 0.001497, "average": 0.972873, "min": 0.868562}, "location": {"width": 462, "top": 500, "height": 29, "left": 474}, "words": "和/或血小板计数<500m3时需要临时暂停本品"}, {"probability": {"variance": 0.002694, "average": 0.973449, "min": 0.699931}, "location": {"width": 782, "top": 545, "height": 36, "left": 196}, "words": "当ANC计数<1000/m3时,可在随后的治疗中同时给予粒细胞集落刺激因子(G-CSF"}, {"probability": {"variance": 0.011605, "average": 0.932555, "min": 0.604758}, "location": {"width": 357, "top": 596, "height": 26, "left": 147}, "words": "orGM1-CSF)治疗,以维持血细胞数量"}, {"probability": {"variance": 1e-06, "average": 0.999212, "min": 0.997512}, "location": {"width": 88, "top": 644, "height": 26, "left": 188}, "words": "特殊病人"}, {"probability": {"variance": 0.008607, "average": 0.96671, "min": 0.571322}, "location": {"width": 838, "top": 690, "height": 41, "left": 143}, "words": "叶功能不全病人:曾对少量肝功能不全病人(胆红素值达4mgdl)给予20mg/m2本品,血"}, {"probability": {"variance": 3.7e-05, "average": 0.996762, "min": 0.970802}, "location": {"width": 669, "top": 742, "height": 36, "left": 309}, "words": "浆清除率和清除半衰期未见变化。根据以往使用盐酸多柔比星的经验,对"}, {"probability": {"variance": 0.002759, "average": 0.977854, "min": 0.764459}, "location": {"width": 667, "top": 790, "height": 36, "left": 311}, "words": "丁肝功能不全的病人应减少给药量。建议当胆红素高于以下数值时考虑减"}, {"probability": {"variance": 0.02142, "average": 0.919023, "min": 0.359024}, "location": {"width": 651, "top": 838, "height": 38, "left": 307}, "words": "少用量:血清胆红素1.2-3.0mg/dl,采用常用量的12人于3.0mgd1时"}, {"probability": {"variance": 0.00407, "average": 0.971861, "min": 0.793084}, "location": {"width": 163, "top": 887, "height": 26, "left": 306}, "words": "采用常用量的1/4"}, {"probability": {"variance": 0.013184, "average": 0.958004, "min": 0.413347}, "location": {"width": 820, "top": 932, "height": 37, "left": 143}, "words": "能不全病人:由于多柔比星由肝脏代谢和经胆汁排泄,故使用本品时剂量不需要调整"}, {"probability": {"variance": 0.023019, "average": 0.946502, "min": 0.42075}, "location": {"width": 617, "top": 979, "height": 37, "left": 139}, "words": "人:日前尚无本品用丁脾切除病人的经验,故不推荐使用"}, {"probability": {"variance": 0, "average": 0.99979, "min": 0.999462}, "location": {"width": 114, "top": 1031, "height": 24, "left": 146}, "words": "【不良反应】"}, {"probability": {"variance": 0.008214, "average": 0.970402, "min": 0.618454}, "location": {"width": 533, "top": 1076, "height": 35, "left": 180}, "words": "以下引口国外上市的盐酸多柔比星脂质体的临床文献资料"}, {"probability": {"variance": 0.008993, "average": 0.97567, "min": 0.423934}, "location": {"width": 791, "top": 1125, "height": 36, "left": 181}, "words": "ADS-KS病人进行的临床开放和对照研究显示,与盐酸多柔比星脂质体相关的最常见"}, {"probability": {"variance": 8.4e-05, "average": 0.993678, "min": 0.971935}, "location": {"width": 430, "top": 1170, "height": 36, "left": 135}, "words": "的不良反应是骨髓抑制,儿乎近一半病人发生"}, {"probability": {"variance": 0.006696, "average": 0.979135, "min": 0.532763}, "location": {"width": 789, "top": 1222, "height": 40, "left": 182}, "words": "白细胞减少是病人最常见的不良反应,也可见贫血和血小板减少。这些反应一般在治"}, {"probability": {"variance": 0.003958, "average": 0.981638, "min": 0.63455}, "location": {"width": 833, "top": 1271, "height": 40, "left": 134}, "words": "早期便可见,但仅是暂时性的。临床试验中很少有因严重骨髓抑制而停药的事件发生。在"}, {"probability": {"variance": 0.006399, "average": 0.97192, "min": 0.57922}, "location": {"width": 679, "top": 1321, "height": 35, "left": 133}, "words": "出现血液学毒性反应时,应按“出现血液毒性的剂量调整”方法进行处理"}, {"probability": {"variance": 0.006489, "average": 0.971217, "min": 0.585091}, "location": {"width": 787, "top": 1367, "height": 42, "left": 179}, "words": "在临球研究使用盐酸多柔比星脂质体过程中,出现的较常见的有临床意义的实验室检"}, {"probability": {"variance": 0.010731, "average": 0.956743, "min": 0.531053}, "location": {"width": 832, "top": 1417, "height": 39, "left": 132}, "words": "查异常(≥5%),还包括碱性磷酸酶升高以及天冬酰胺转移酶利胆红素升高,但这些检查异"}, {"probability": {"variance": 0.006216, "average": 0.968402, "min": 0.622453}, "location": {"width": 836, "top": 1465, "height": 41, "left": 127}, "words": "常被认为与基础病有关,而与盐酸多柔比星脂质体无关。根据报道,在使用盐酸多柔比星"}, {"probability": {"variance": 0.013236, "average": 0.951059, "min": 0.495114}, "location": {"width": 836, "top": 1514, "height": 39, "left": 126}, "words": "脂质你的过程中,血红蛋白和血小板减少的发生率较低(<5%),白细胞减少导致的脓毒血"}, {"probability": {"variance": 0.00524, "average": 0.973565, "min": 0.587405}, "location": {"width": 835, "top": 1561, "height": 41, "left": 125}, "words": "更为少见(<1%)。上述某些检测指标异常的产生可能与HIV感染有关,而非盐酸多柔"}], "language": 3}